Reflections on HIS 2014: in praise of enthusiasts

Published:February 12, 2015DOI:


      Medical conferences have had a bad press recently. They have been accused of leaving nothing but indifferent research and an enormous carbon footprint. They are also likely to contribute to ‘intervention bias’ in healthcare, in that the speakers tend to be selected from among the more enthusiastic interventionists and charismatic optimists. But this weakness is arguably also an important strength, for they can be the vehicle by which participants are inspired to innovate and evaluate. It is difficult to predict the outcome of interventions aimed at prevention and control of infection because they involve interactions between people and complex systems, not to mention the invisible agents of infection. Progress therefore depends largely on the empirical approach – trial and error. In this context we need both enthusiasts to inspire trial and sceptics to expose error. Conferences deserve support for encouraging debate between enthusiasts and sceptics, for providing a forum for cross-fertilization between sub-specialties, and for inspiring trainees as well as practitioners. The papers presented in this issue of JHI illustrate the wide range of contemporary challenges in healthcare-associated infection, and summarize the ‘state of the art’ of infection prevention and control.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Hospital Infection
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Callister M.E.J.
        • Griffiths M.J.D.
        The carbon footprint of the American Thoracic Society meeting.
        Am J Resp Crit Care Med. 2007; 175: 417
        • Green G.
        Are international medical conferences an outdated luxury the planet can't afford? Yes.
        BMJ. 2008; 336: 1466
        • Moynihan R.
        Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: entanglement.
        BMJ. 2003; 326: 1189
        • Willett M.
        Artwork on the cover of the print issue of.
        BMJ. 2003; 326
        • Ioannidis J.P.A.
        Are medical conferences useful? And for whom?.
        JAMA. 2012; 307: 1257-1258
        • Ioannidis J.P.A.
        Why most published research findings are false.
        PLoS Medicine. 2005; 2: e124
        • Association of the British Pharmaceutical Industry
        Code of practice for the pharmaceutical industry.
        ABPI, London2015 (accessed 02.02.2015)
        • Hawkey P.
        Multidrug-resistant Gram-negative bacteria: a product of globalization.
        J Hosp Infect. 2015; 89: 241-247
        • de Bono S.
        • Heling G.
        • Borg M.A.
        Organisational culture and its implications for infection prevention and control in healthcare institutions.
        J Hosp Infect. 2014; 86: 1-6
        • Foy A.J.
        • Filippone E.J.
        The case for intervention bias in the practice of medicine.
        Yale J Biol Med. 2013; 86: 271-280
        • Geison G.L.
        Laboratory notebooks, scientific fraud and the rhetorical construction of scientific knowledge.
        in: The private science of Louis Pasteur. Princeton University Press, Princeton, NJ1995 (p. 11–16)
      1. Piot P. Interview with Kirsty Young on Desert Island Discs, BBC Radio 4. Broadcast January 30th, 2015. (accessed 03.02.2015).

        • Seto W.-H.
        Airborne transmission and precautions: facts and myths.
        J Hosp Infect. 2015; 89: 225-228
        • Munoz-Price L.S.
        Controlling multidrug resistant Gram-negative bacilli in your hospital: a transformational journey.
        J Hosp Infect. 2015; 89: 254-258
        • Centres for Disease Prevention and Control
        Antibiotic resistance threats in the United States.
        2013 (accessed 03.02.2015)
      2. World Health Organization. Antimicrobial resistance: global report on surveillance. ISBN 978 92 4 156474 8. (accessed 02.02.2015).

        • Kirby A.
        • Santoni N.
        Antibiotic resistance in Enterobacteriaceae: what impact on the efficacy of antibiotic prophylaxis in colorectal surgery?.
        J Hosp Infect. 2015; 89: 259-263
        • Pew Charitable Trusts
        Research and development: tracking the pipeline of antibiotics in development.
        2014 (accessed 02.02.2015)
        • Semin-Pelletier B.
        • Cazet L.
        • Bourigault C.
        • et al.
        Challenges of controlling a large outbreak of OXA-48 carbapenemase-producing Klebsiella pneumoniae in a French university hospital.
        J Hosp Infect. 2015; 89: 248-253
        • Brusaferro S.
        • Arnoldo L.
        • Cattani G.
        • et al.
        Harmonising and supporting infection control training in Europe.
        J Hosp Infect. 2015; 89: 351-356
        • O'Riordan M.
        • Fitzpatrick F.
        The impact of economic recession on infection prevention and control.
        J Hosp Infect. 2015; 89: 340-345
        • Çakmakçi M.
        Antibiotic stewardship and the surgeon's role.
        J Hosp Infect. 2015; 89: 264-266
        • Burns K.
        • Rocha F.
        • Donlon S.
        Healthcare-associated infections and antimicrobial use in long-term care facilities: the Irish experience with the HALT surveys.
        J Hosp Infect. 2015; 89: 276-280
        • Castro-Sánchez E.
        • Holmes A.H.
        Impact of organizations on healthcare-associated infections.
        J Hosp Infect. 2015; 89: 346-350
        • Marschang S.
        • Bernardo G.
        Prevention and control of healthcare-associated infection (HAI) in Europe – a review of patients' perspectives and existing differences.
        J Hosp Infect. 2015; 89: 357-362
        • Walker J.
        • Moore G.
        Pseudomonas aeruginosa in hospital water systems: biofilms, guidelines, and practicalities.
        J Hosp Infect. 2015; 89: 324-327
        • Reilly J.S.
        • McCoubrey J.
        • Cole S.
        • Khan A.
        • Cook B.
        Integrating ICU surveillance into an ICU clinical care electronic system.
        J Hosp Infect. 2015; 89: 271-275
        • Wyllie D.
        • Davies J.
        Role of data warehousing in healthcare epidemiology.
        J Hosp Infect. 2015; 89: 267-270
        • Humphrey H.
        • Jenks P.J.
        Surveillance and management of ventriculitis following neurosurgery.
        J Hosp Infect. 2015; 89: 282-286
        • Parniex P.
        How infection control teams can assess their own performance and enhance their prestige using activity and outcome indicators for public reporting.
        J Hosp Infect. 2015; 89: 328-330
        • Kambhampati A.
        • Koopmans M.
        • Lopman B.A.
        Burden of norovirus in healthcare facilities and strategies for outbreak control.
        J Hosp Infect. 2015; 89: 296-301
        • Schaffer K.
        Epidemiology of infection and current guidelines for infection prevention in cystic fibrosis patients.
        J Hosp Infect. 2015; 89: 309-313
        • Barbut F.
        How to eradicate Clostridium difficile from the environment.
        J Hosp Infect. 2015; 89: 287-295
        • Bouscambert-Duchamp M.
        • Valette M.
        • Lina B.
        Rapid bedside tests for diagnosis, management and prevention of nosocomial influenza.
        J Hosp Infect. 2015; 89: 314-318
        • Eggimann P.
        • Que Y.-A.
        • Revelly J.-P.
        • Pagani J.-L.
        Preventing invasive candida infections. Where could we do better?.
        J Hosp Infect. 2015; 89: 302-308
        • Sax H.
        • Clack L.
        Mental models: a basic concept for human factors design in infection prevention.
        J Hosp Infect. 2015; 89: 335-339
        • Venier A.-G.
        Root cause analysis to support infection control in healthcare premises.
        J Hosp Infect. 2015; 89: 331-334
        • Otter J.
        What's trending in the infection prevention and control literature? From HIS 2012 to HIS 2014, and beyond.
        J Hosp Infect. 2015; 89: 229-236
        • Gray J.
        Infection control: beyond the horizon.
        J Hosp Infect. 2015; 89: 237-240